http://fasb.org/us-gaap/2024#其他长期资产http://fasb.org/us-gaap/2024#其他长期资产http://fasb.org/us-gaap/2024#其他流动负债http://fasb.org/us-gaap/2024#其他流动负债http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent0001039065--06-302025Q1错误0000错误错误错误错误错误错误http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember0001039065US-GAAP:普通股成员2024-09-300001039065us-gaap:留存收益成员2024-09-300001039065us-gaap:其他综合收益的累计成员2024-09-300001039065us-gaap:留存收益成员2024-06-300001039065us-gaap:其他综合收益的累计成员2024-06-300001039065us-gaap:留存收益成员2023-09-300001039065us-gaap:其他综合收益的累计成员2023-09-300001039065us-gaap:留存收益成员2023-06-300001039065us-gaap:其他综合收益的累计成员2023-06-300001039065美国通用会计原则:普通股,包括额外已付股本的成员2024-09-300001039065美国通用会计原则:普通股,包括额外已付股本的成员2024-06-300001039065美国通用会计原则:普通股,包括额外已付股本的成员2023-09-300001039065美国通用会计原则:普通股,包括额外已付股本的成员2023-06-300001039065US-GAAP:员工股票期权成员2024-06-300001039065srt:AsiaPacificMember2024-09-300001039065美国通用会计原则限制性股票单位累计成员2024-06-300001039065country:US2024-07-012024-09-300001039065country:US2023-07-012023-09-3000010390652024-10-012024-09-300001039065us-gaap:设施关闭成员。2024-09-300001039065us-gaap:EmployeeSeveranceMember2024-09-300001039065与收购相关的费用成本的美国通用会计准则2024-09-300001039065srt:MaximumMember2024-09-300001039065us-gaap:设施关闭成员。2024-06-300001039065us-gaap:EmployeeSeveranceMember2024-06-300001039065与收购相关的费用成本的美国通用会计准则2024-06-300001039065srt:MaximumMember2024-06-300001039065us-gaap:租赁改善成员2024-09-300001039065美国通用会计准则:土地成员2024-09-300001039065us-gaap:家具和固定资产会员2024-09-300001039065us-gaap:设备会员2024-09-300001039065在建工程2024-09-300001039065us-gaap:ComputerSoftwareIntangibleAssetMember2024-09-300001039065美国通用会计准则:计算机设备成员2024-09-300001039065US-GAAP:建筑和建筑改良会员2024-09-300001039065us-gaap:NonqualifiedPlanMember2024-09-300001039065us-gaap:租赁改善成员2024-06-300001039065美国通用会计准则:土地成员2024-06-300001039065us-gaap:家具和固定资产会员2024-06-300001039065us-gaap:设备会员2024-06-300001039065在建工程2024-06-300001039065us-gaap:ComputerSoftwareIntangibleAssetMember2024-06-300001039065美国通用会计准则:计算机设备成员2024-06-300001039065US-GAAP:建筑和建筑改良会员2024-06-300001039065us-gaap:NonqualifiedPlanMember2024-06-300001039065srt:ChiefExecutiveOfficerMember2024-07-192024-07-190001039065us-gaap:其他综合收益的累计成员2024-07-012024-09-300001039065us-gaap:其他综合收益的累计成员2023-07-012023-09-300001039065us-gaap:运营业务细分会员us-gaap:OperatingSegmentsMember2024-07-012024-09-300001039065us-gaap:运营业务细分会员srt:MinimumMember2024-07-012024-09-300001039065跨业务板块清算成员2024-07-012024-09-300001039065us-gaap:企业非部门会员2024-07-012024-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-07-012024-09-300001039065us-gaap:运营业务细分会员us-gaap:OperatingSegmentsMember2023-07-012023-09-300001039065us-gaap:运营业务细分会员srt:MinimumMember2023-07-012023-09-300001039065跨业务板块清算成员2023-07-012023-09-300001039065us-gaap:企业非部门会员2023-07-012023-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-07-012023-09-300001039065us-gaap:企业成员2023-07-012023-09-300001039065srt:最小成员us-gaap: 循环信贷设施成员2024-09-300001039065us-gaap: 循环信贷设施成员2024-09-300001039065osis:CustomerTwoMember2024-09-300001039065美国公认会计原则:授信额度成员2024-09-300001039065us-gaap:CustomerConcentrationRiskMember2024-09-300001039065us-gaap:商标会员2024-09-300001039065us-gaap:商标会员2024-06-300001039065us-gaap:OperatingSegmentsMember2024-07-012024-09-300001039065srt:MinimumMember2024-07-012024-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-07-012024-09-300001039065us-gaap:OperatingSegmentsMember2024-09-300001039065srt:MinimumMember2024-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-09-300001039065us-gaap:OperatingSegmentsMember2024-06-300001039065srt:MinimumMember2024-06-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-06-300001039065us-gaap:软件和软件开发成本会员2024-09-300001039065专利成员2024-09-300001039065us-gaap:已开发技术权益成员2024-09-300001039065osis:SecurityDivisionMember2024-09-300001039065us-gaap:软件和软件开发成本会员2024-06-300001039065专利成员2024-06-300001039065us-gaap:已开发技术权益成员2024-06-300001039065osis:SecurityDivisionMember2024-06-300001039065美国通用会计原则限制性股票单位累计成员2024-07-012024-09-300001039065US-GAAP:员工股票期权成员2024-07-012024-09-300001039065美国通用会计原则限制性股票单位累计成员2024-09-300001039065US-GAAP:员工股票期权成员2024-09-300001039065美国通用会计准则:外汇远期成员2024-09-300001039065美国通用会计准则:外汇远期成员2024-06-300001039065 2024-09-300001039065 2024-06-300001039065srt:ChiefExecutiveOfficerMember2024-07-310001039065OSIS:指定期间之后连续五个工作日会员2024-07-012024-09-300001039065OSIS:2024年9月30日结束的季度之后的日历季度会员2024-07-012024-09-300001039065srt:ChiefExecutiveOfficerMember2024-07-012024-09-300001039065srt:最小成员us-gaap: 循环信贷设施成员2024-07-012024-09-300001039065srt:最大成员us-gaap: 循环信贷设施成员2024-07-012024-09-300001039065us-gaap: 循环信贷设施成员2024-07-012024-09-300001039065us-gaap:服务成员2024-07-012024-09-300001039065US GAAP: 产品成员2024-07-012024-09-300001039065us-gaap:服务成员2023-07-012023-09-300001039065US GAAP: 产品成员2023-07-012023-09-300001039065us-gaap:FairValueInputsLevel2Member2024-09-300001039065srt:ChiefExecutiveOfficerMember2024-09-300001039065奥斯斯:私人无线电频技术提供商会员2024-09-300001039065us-gaap:FairValueMeasurementsRecurringMember美国通用会计原则:应收账款成员us-gaap:客户集中度风险成员us-gaap:OperatingSegmentsMember2024-07-012024-09-300001039065srt:AsiaPacificMember美国通用会计原则:应收账款成员us-gaap:客户集中度风险成员us-gaap:OperatingSegmentsMember2024-07-012024-09-300001039065osis:没有客户会员美国通用会计原则:应收账款成员us-gaap:客户集中度风险成员2024-07-012024-09-300001039065osis:没有客户会员美国通用会计原则:应收账款成员us-gaap:客户集中度风险成员2023-07-012024-06-300001039065us-gaap:FairValueMeasurementsRecurringMember美国通用会计准则:净销售收入会员us-gaap:客户集中度风险成员us-gaap:OperatingSegmentsMember2023-07-012023-09-3000010390652023-09-3000010390652023-06-300001039065us-gaap:软件和软件开发成本会员2024-01-012024-09-300001039065us-gaap:软件和软件开发成本会员2023-01-012023-09-300001039065srt:MinimumMember2024-07-012024-09-300001039065srt:MinimumMember2023-07-012023-09-300001039065奥西斯:提供重要军事空间和监视解决方案的私营公司成员2024-07-012024-09-300001039065美国公认会计原则(US-GAAP):公允价值输入级别3成员us-gaap:重复计量公允价值会员2024-09-300001039065美国公认会计原则(US-GAAP):公允价值输入级别3成员us-gaap:重复计量公允价值会员2024-06-300001039065us-gaap:一系列不重要的营业收购2024-09-300001039065xbrli:shares2023-10-310001039065iso4217:USD2023-12-012023-12-310001039065xbrli:shares2023-10-012023-10-310001039065us-gaap:OperatingSegmentsMember2024-07-012024-09-300001039065其他运营效率活动成员2024-07-012024-09-300001039065us-gaap:OperatingSegmentsMember2023-07-012023-09-300001039065其他运营效率活动成员2023-07-012023-09-300001039065us-gaap:运营业务细分会员us-gaap:OperatingSegmentsMember2024-09-300001039065us-gaap:运营业务细分会员srt:MinimumMember2024-09-300001039065跨业务板块清算成员2024-09-300001039065us-gaap:企业非部门会员2024-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-09-300001039065us-gaap:运营业务细分会员us-gaap:OperatingSegmentsMember2024-06-300001039065us-gaap:运营业务细分会员srt:MinimumMember2024-06-300001039065跨业务板块清算成员2024-06-300001039065us-gaap:企业非部门会员2024-06-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-06-300001039065srt:ChiefExecutiveOfficerMember2024-07-012024-09-300001039065销售总费用成员2024-07-012024-09-300001039065US-GAAP:研发费用成员2024-07-012024-09-300001039065美国通用会计准则:销售成本成员2024-07-012024-09-300001039065销售总费用成员2023-07-012023-09-300001039065US-GAAP:研发费用成员2023-07-012023-09-300001039065美国通用会计准则:销售成本成员2023-07-012023-09-300001039065us-gaap:留存收益成员2024-07-012024-09-300001039065美国通用会计原则:普通股,包括额外已付股本的成员2024-07-012024-09-300001039065us-gaap:留存收益成员2023-07-012023-09-300001039065美国通用会计原则:普通股,包括额外已付股本的成员2023-07-012023-09-300001039065srt:最小成员osis:提供关键军事空间和监视解决方案的私营公司成员2024-09-012024-09-300001039065srt:最大成员osis:提供关键军事空间和监视解决方案的私营公司成员2024-09-012024-09-300001039065US-GAAP:普通股成员2022-09-300001039065srt:最小成员country:US2024-07-012024-09-300001039065srt:最大成员country:US2024-07-012024-09-300001039065美国通用会计原则限制性股票单位累计成员srt:AsiaPacificMember2024-07-012024-09-300001039065us-gaap:设施关闭成员。2024-07-012024-09-300001039065us-gaap:EmployeeSeveranceMember2024-07-012024-09-300001039065与收购相关的费用成本的美国通用会计准则2024-07-012024-09-300001039065srt:MaximumMember2024-07-012024-09-300001039065srt:最大成员us-gaap: 循环信贷设施成员2024-09-300001039065us-gaap:FairValueInputsLevel2Memberus-gaap:重复计量公允价值会员2024-09-300001039065us-gaap:重复计量公允价值会员2024-09-300001039065us-gaap:FairValueInputsLevel2Memberus-gaap:重复计量公允价值会员2024-06-300001039065us-gaap:重复计量公允价值会员2024-06-3000010390652023-07-012023-09-300001039065srt:ChiefExecutiveOfficerMember2024-07-012024-07-310001039065srt:ChiefExecutiveOfficerMember2024-09-3000010390652024-09-3000010390652024-06-300001039065美国通用会计原则:应收账款成员us-gaap:OperatingSegmentsMember2024-07-012024-09-300001039065美国通用会计准则:净销售收入会员2024-07-012024-09-300001039065美国通用会计原则:应收账款成员2023-07-012024-06-300001039065osis:提供关键军事空间和监视解决方案的私人持有提供者会员2024-09-300001039065osis:提供关键军事空间和监视解决方案的私人持有提供者会员2024-09-012024-09-3000010390652024-10-2100010390652024-07-012024-09-30xbrli:股份iso4217:美元指数xbrli:纯形客户iso4217:美元指数xbrli:股份D细分

目录

美国
证券交易委员会

华盛顿特区20549

表格10-Q

(标记一)

根据1934年证券交易法第13或15(d)条,本季度报告

截至季度结束日期的财务报告2024年9月30日

或者

根据1934年证券交易法第13或15(d)条的转型报告

过渡期从             到               

委员会文件号 000-23125

Graphic

致富金融(临时代码)系统公司,公司。

(根据其章程规定的注册人准确名称)

特拉华州

    

33-0238801

(国家或其他管辖区的
公司成立或组织)

(IRS雇主
唯一识别号码)

请在对勾内选择是否注册人(1) 在过去12个月内按照1934年证券交易所法第13条或15(d)条的规定提交了所有需要提交的报告(或者对于注册人需要提交这些报告的较短期间),以及(2) 在过去的90天内一直受到这些提交要求的约束。

霍桑, 加利福尼亚州 90250

(总部地址)(邮政编码)

(310) 978-0516

(注册人电话号码,包括区号)

无数据

(前名称、地址及财政年度,如果自上次报告以来有更改)

在法案第12(b)条的规定下注册的证券:

每一类的名称

    

交易标志

    

在其上注册的交易所的名称

普通股,每股0.001美元面值

OSIS

本基金寻求于东欧地区注册的主要权益关联发行人的长期升值投资。纳斯达克资本市场全球货币选择市场

请在以下勾选,并注明是否为以下两项:(1)在过去12个月内(或注册者需要提交此类报告的较短期间内)提交所有必须提交的根据1934年证券交易法第13或第15(d)条规定提交的报告,并且(2)在过去90天内受到此类提交要求的要求。(小型报告公司) 

请在以下勾选方框表示注册人是否已在Regulation S-T Rule 405规定的前12个月(或在注册人需要提交此类文件的较短期间内)提交了每个互动数据文件。

请勾选标记以说明注册人是大型快速申报人、加速申报人、非加速申报人、较小的报告公司还是新兴成长型公司。请查看《交易所法》第120亿.2条中“大型快速申报人”、“加速申报人”、“较小的报告公司”和“新兴成长型公司”的定义。

大型加速报告人 

   

如果是新兴增长公司,请勾选是否注册人选择不使用执行交易所第13(a)条规定所提供的任何新的或修订的财务会计准则的推迟过渡期。 ☐

非加速归档企业

小型报表公司

新兴成长公司

如果是新兴成长型企业,请勾选复选标记,表明注册者已选择不使用延长过渡期来符合根据证券交易法第13(a)条规定提供的任何新财务会计准则。

请勾选表示注册申报人是否为外壳公司(根据交易所12b-2号规则定义)。是

截至2024年10月21日,有 16,710,749 股普通股股票。

目录

致富金融(临时代码)系统公司,公司。

指数

页码

第I部分—财务信息

3

项目1—

基本报表(未经审计)

3

2024年6月30日和2024年9月30日的简明综合资产负债表

3

截至2023年和2024年9月30日为止三个月的简明综合损益表

4

截至2023年和2024年9月30日为止三个月的简明综合收益表

5

截至2023年和2024年9月30日为止三个月的简明综合股东权益表

6

截至2023年和2024年9月30日的精简合并现金流量表 2023年和2024年9月30日结束的三个月

7

压缩合并财务报表附注

8

项目2—

分销计划

23

项目3—

市场风险的定量和定性披露

28

项目 4 —

控制和程序

29

第二部分——其他信息

30

项目 1 —

法律诉讼

30

项目1A—

风险因素

30

项目2—

未注册的股票股权销售和筹款用途

30

项目3—

对优先证券的违约

30

项目4—

矿山安全披露

30

项目5 -

其他信息

30

项目6 -

展示资料

31

签名

32

2

目录

第一部分—财务信息

项目1.基本报表

OSI SYSTEMS,INC.及附属公司

简化联合资产负债表(未经审计)

(金额以千为单位,股份数量和面值除外)

6月30日,

2021年9月30日

    

2024

    

2024

资产

流动资产:

现金及现金等价物

$

95,353

$

85,053

2,687,823 

 

648,155

687,610

存货

 

397,939

456,030

预付费用和其他流动资产

 

74,077

81,310

总流动资产

 

1,215,524

1,310,003

资产和设备,净值

 

113,967

124,613

商誉

 

351,480

381,444

无形资产, 净额

 

139,529

183,222

其他

 

115,508

114,232

总资产

$

1,936,008

$

2,113,514

负债和股东权益

流动负债:

银行信贷额度

$

384,000

$

259,000

开多次数

 

8,167

8,217

应付账款

 

191,149

191,932

应计的工资和相关费用

 

46,732

41,048

来自客户预付款

 

53,431

63,996

其他应计费用和流动负债

 

131,158

148,343

流动负债合计

 

814,637

712,536

长期负债净额

 

129,383

468,084

其他长期负债

 

128,505

146,399

负债合计

 

1,072,525

1,327,019

股东权益:

6.40

优先股,$0.00010.001授权股份于2024年5月4日和2024年2月3日分别为10,000,000已授权股份;无发行或流通的股份

 

普通股,每股面值为 $0.0001;0.001授权股份于2024年5月4日和2024年2月3日分别为100,000,000 授权股份;已发行及流通股份, 17,055,497在2024年6月30日为已发行流通股份,在2023年12月31日为已发行流通股份16,710,749 截至2024年9月30日,股份

 

24,289

17

保留盈余

 

861,230

810,553

累计其他综合损失

 

(22,036)

(24,075)

股东权益总额

 

863,483

786,495

负债和股东权益总额

$

1,936,008

$

2,113,514

请参阅附注事项的简明合并财务报表。

3

目录

OSI 系统公司和子公司

简明合并运营报表(未经审计)

(金额以千计,每股数据除外)

截至9月30日的三个月

    

2023

    

2024

净收入:

产品

$

199,709

$

255,808

服务

 

79,501

88,199

净收入总额

 

279,210

344,007

销售商品的成本:

产品

 

136,983

170,422

服务

 

43,482

52,083

销售商品的总成本

 

180,465

222,505

毛利润

 

98,745

121,502

运营费用:

销售、一般和管理

 

59,798

72,223

研究和开发

 

15,922

17,773

重组和其他费用,净额

 

466

1,178

运营费用总额

 

76,186

91,174

运营收入

 

22,559

30,328

利息和其他费用,净额

 

(5,748)

(7,359)

所得税前收入

 

16,811

22,969

所得税准备金

 

(3,932)

(5,033)

净收入

$

12,879

$

17,936

每股收益:

基本

$

0.77

$

1.07

稀释

$

0.75

$

1.05

每股计算中使用的股份:

基本

 

16,825

16,742

稀释

 

17,175

17,055

参见简明合并财务报表的附注。

4

目录

OSI SYSTEMS,INC.及附属公司

基本报表综合损益表(未经审计)

(金额以千为单位)

    

截至9月30日,三个月的结束

    

2023

    

2024

净利润

$

12,879

$

17,936

其他综合收益(损失):

外币兑换损益,扣除税金

 

(3,172)

1,181

衍生工具的净未实现收益(损失),税后

1,147

(3,220)

其他,税后净额。

137

其他综合损失

(1,888)

(2,039)

综合收益

$

10,991

$

15,897

请参阅附注事项的简明合并财务报表。

5

目录

OSI SYSTEMS,INC.及附属公司

未经审计的凝聚的股东权益合并报表

(金额以千为单位,除每股数据外)

2023年9月30日结束的三个月

累积的

普通股

其他

    

股数

    

    

留存收益

    

综合

    

    

股份

    

数量

    

收益

    

损失

    

总费用

资产负债表—2023年6月30日

 

16,755,772

$

9,835

$

735,957

$

(19,627)

$

726,165

行使股票期权

 

4,752

420

420

限制性股票单位的解除限制

 

363,820

员工股票购买计划下发行的股票

 

29,813

2,031

2,031

股票补偿费用

 

7,089

7,089

与股份奖励净结算相关的支付的税额

 

(166,315)

(19,358)

(2,881)

(22,239)

净收入

 

12,879

12,879

其他综合损失

 

(1,888)

(1,888)

资产负债表-2023年9月30日

16,987,842

$

17

$

745,955

$

(21,515)

$

724,457

2024年9月30日结束的三个月

累积的

普通股

其他

    

股数

    

    

留存收益

    

综合

    

    

股份

    

数量

    

收益

    

损失

    

总费用

结余-2024年6月30日

17,055,497

$

24,289

$

861,230

$

(22,036)

$

863,483

行使股票期权

957

70

70

限制性股票单位的解除限制

297,418

员工股票购买计划下发行的股票

31,143

2,329

2,329

股票补偿费用

6,422

6,422

回购普通股

(531,314)

(28,919)

(51,524)

(80,443)

与股份奖励净结算相关的支付的税额

(142,952)

(4,174)

(17,089)

(21,263)

净收入

17,936

17,936

其他综合损失

(2,039)

(2,039)

资产负债表-2024年9月30日

 

16,710,749

$

17

$

810,553

$

(24,075)

$

786,495

6

目录

OSI SYSTEMS,INC.及附属公司

未经审计的简明合并现金流量表

(金额以千为单位)

截至9月30日,三个月的结束

    

2023

    

2024

经营活动产生的现金流量

    

净收入

$

12,879

$

17,936

折旧和摊销

 

9,568

11,450

股票补偿费用

 

7,089

6,422

应收账款损失的回收

(433)

(427)

延迟所得税

208

(851)

摊销债务折扣和发行成本

 

354

其他

 

42

(21)

业务收购前后经营资产和负债的变动:

应收账款

 

55,868

(30,187)

存货

 

(82,035)

(54,458)

预付款项和其他资产

 

(7,605)

(23,325)

应付账款

 

25,851

(4,952)

应计的工资和相关费用

(6,606)

(7,811)

来自客户预付款

 

10,770

10,267

递延收入

(7,142)

11,485

其他

 

(1,310)

26,958

经营活动产生的净现金流量

 

17,144

(37,160)

投资活动产生的现金流量

购置房地产和设备

 

(5,239)

(7,705)

出售固定资产的收益

44

85

存入资金购买存单

(2,068)

来自存单到期的收益

1,839

业务收购,扣除现金收购

 

(75,500)

支付无形资产和其他资产

 

(4,154)

(4,372)

投资活动产生的净现金流出

 

(9,578)

(87,492)

筹资活动产生的现金流量

银行信贷额度上的净借款(还款)

 

20,000

(125,000)

获得长期债务

 

394

340,475

开多期债偿付款

 

(2,073)

(2,078)

行权期权和员工股票购买计划所得款项

 

2,451

2,399

支付或准备支付的参考负债

(383)

(331)

回购普通股

 

(80,443)

与股份奖励净结算相关的支付的税额

 

(22,239)

(21,263)

筹集资金的净现金流量

 

(1,850)

113,759

汇率变动对现金的影响

 

125

593

现金及现金等价物的净增加(减少)

 

5,841

(10,300)

现金及现金等价物—期初余额

 

76,750

95,353

现金及现金等价物—期末余额

$

82,591

$

85,053

现金流量补充披露:

期间支付的净现金

利息

$

5,455

$

5,231

所得税

$

6,795

$

13,540

请参阅附注事项的简明合并财务报表。

7

目录

OSI SYSTEMS,INC.及附属公司

简明合并财务报表附注

(未经审计)

1.报表的基础

简明综合财务报表包括OSI Systems,Inc.及其子公司的账户。所有重要的公司间账户和交易在合并中已被消除。简明综合财务报表是由管理层按照美国通用会计原则(“GAAP”)和与美国证券交易委员会(“SEC”)的规则和法规一起编制的。根据SEC的规则和法规以及适用于未经审计的中期财务报表的GAAP要求,某些年度财务报表所需的信息和脚注披露已被简化或排除。因此,简明综合财务报表不包括GAAP要求的所有年度财务报表所需的信息和脚注。据管理层意见,简明综合财务报表反映了出于公平呈现中期所示结果而被认为是必要的常规性质的所有调整。这些建议的简明综合财务报表和所附说明应与我们2024财年截至6月30日的已向SEC提交的10-k表格年度报告中包括的审计合并财务报表和所附说明一起阅读。2024年9月30日结束的三个月的运营结果不一定能体现预期的2025财年整个期间或任何未来期间的运营结果。

使用估计

根据GAAP要求编制符合会计准则的基本财务报表,需要管理层对资产和负债的报告金额、与规定的资产和负债有关的披露,以及销售金额、销售成本和报表期间费用的金额进行估计和假设。由于涉及到估计和假设,对于我们公司来说,最重要的估计和假设涉及合同收入、企业并购中取得的资产的公允价值和承担的负债、按成本或净可变现价值较低报告的存货价值、以市场为基础的股票补偿费用、所得税、应计质保费用、有关的考虑、坏账准备、以及长期资产、可识别无形资产和商誉的计量、有用寿命和估计金额的回收性等。估计的变化将在知晓的期间内反映。由于估计涉及的固有不确定性,我们未来报告的实际金额与估计金额可能有实质差异。

每股收益计算

我们通过将归属于普通股股东的净利润除以期间内普通股平均股数来计算基本每股收益。我们通过将归属于普通股股东的净利润除以期间内普通股平均股数和潜在稀释性普通股数的和来计算稀释每股收益。潜在普通股包括根据库藏股法行使股票期权和限制性股票单元奖励而发行的股份。基础权益组成部分 2.252029年到期的可转换高级票据(“2029年票据”)在简明合并财务报表的第8号注解中讨论,当我们的普通股平均价格超过每股转换价$时,将对稀释每股收益产生净影响191.98 由于2029年债券的本金金额在兑换时以现金结算。截至2024年9月30日止三个月,2029年债券并无稀释效应。

下表列出基本每股收益和摊薄每股收益的计算(以千为单位,除每股金额外):

    

截至9月30日,三个月的结束

2023

    

2024

净利润可供普通股股东分配

$

12,879

$

17,936

 

16,825

16,742

股权奖励的稀释效应

 

350

313

稀释后加权平均发行股份

 

17,175

17,055

基本每股收益

$

0.77

$

1.07

摊薄每股收益

$

0.75

$

1.05

由于其抗稀释效应而被排除在稀释每股收益之外的股份

8

22

8

目录

现金及现金等价物

我们将所有到期日在收购日期之日起三个月或更短期限的高度流动的投资视为现金等价物。

截至2023年和2024年6月30日,我们的现金及现金等价物总额分别为$85.1 2024年9月30日的总额为百万美元。其中,大约 81%由我们的外国子公司持有,受赎回税考虑。这些外国资金主要由我们在印度、英国、新加坡、加拿大和马来西亚的子公司持有,而在墨西哥、埃及、印度尼西亚、阿尔巴尼亚和澳大利亚等其他国家的子公司持有较少。我们在金融机构持有超过此类金融机构的保险限额的现金;但是,我们通过利用我们认为信用质量高的国际金融机构来降低这一风险。

金融工具的公允价值

我们的财务工具主要包括现金及现金等价物、保险公司合同、应收账款、应付账款、债务工具、利率互换合同和外币远期合同。除长期债务工具和我们的利率互换合同外,财务工具的账面价值由于其短期到期性质而代表其公允价值。我们的长期债务工具的账面价值被认为近似其公允价值,因为这些工具的利率是变量的或与我们可以获得的当前融资利率相当。截至2024年6月30日和2024年9月30日,我们的外币远期合同的公允价值并不重要。

公允价值是在计量日期市场参与者之间进行有序交易时,在资产销售或过户负债时将收到的价格或支付的价格。"一级"类别包括在活跃市场上报价的相同资产和负债。"二级"类别包括除报价市场价格之外的可观察输入的资产和负债。"三级"类别包括用于公允价值衡量的估值技术是未观察到且对公允价值测量具有重大影响的资产和负债。我们与收购相关的计提支付义务,详见简明合并财务报表附注10,为公允价值衡量目的属于"三级"类别。

我们的财务资产和负债的公允价值分别按以下方式分类(以千为单位):

    

2024年6月30日

    

2024年9月30日

    

第一层次

    

第二层次

    

第三层次

    

总费用

    

第一层次

    

第二层次

    

第三层次

    

总费用

我公司截至2023年和2024年6月30日的外汇远期合约的未实现收益和损失均不显著。

$

$

49,679

$

$

49,679

$

$

52,430

$

$

52,430

资产 – 利率互换合同

$

$

4,735

$

$

4,735

$

$

676

$

$

676

Liabilities—Convertible debt

$

$

$

$

$

$

363,552

$

$

363,552

负债-附带条件支出

$

$

$

15,375

$

15,375

$

$

$

24,246

$

24,246

衍生工具和对冲活动

我们对衍生工具的使用包括外币远期合约和利率互换协议。我们利用外币远期合约部分减轻某些资产负债表暴露,或将其用作净投资套期保值工具,以防范短期外币波动带来的潜在变化。这些合约的原始到期期限最长为三个月。我们还通过衍生工具管理利率变化风险。我们使用固定利率互换来有效地将部分变动利率付款转换为固定利率付款。我们不会出于投机目的使用套期保值工具。

来自我们的外币远期合约的净收益或损失,并未被指定为套期工具,将在合并利润表中报告,截至2023年9月30日和2024年的三个月内,报告的金额并不显著。我们外币远期合约的公允价值是使用标准估值模型和合同期内基于市场的可观察性输入进行估算的。未实现收益被确认为资产,未实现损失被确认为负债。截至2024年6月30日和2024年9月30日,我们持有的外币远期合约名义金额共计$96.4万美元和101.7 分别为0.1亿美元和0.2百万美元。 截至2024年6月30日和2024年9月30日,我们的外汇远期合同未实现的收益和损失并不重要。

9

目录

我们进行利率互换协议是为了改善与基于担保隔夜融资利率(“SOFR”)债务相关的利息支付的现金流可预测性。该利率互换于2026年12月到期。利率互换被视为有效的现金流量套期保值,并且因此,该工具上的净收益或损失作为其他综合收益(损失)的组成部分,在我们的合并财务报表中报告,并在被套期限的基础利率影响盈利时重新分类为净利润。利率互换套期保值的定性和定量评估每季度进行一次,除非事实和情况表明对冲可能不再高度有效。

截至2024年6月30日和2024年9月30日,被指定为利率互换套期保值的衍生工具名义金额为$ million。175 截至2024年6月30日和2024年9月30日,利率互换合同的公允价值记录在合并资产负债表的其他资产中。

现金流量套期保值对其他综合收益(损失)和收益的影响如下所示:

    

截至9月30日,三个月的结束

2023

    

2024

在压缩的合并利润表中呈现的总利息和其他费用净额中记录了现金流避险的影响

$

(5,748)

$

(7,359)

其他综合收益(损失)(税后净额)

1,147

(3,220)

从累积其他综合收益(损失)重新分类的金额,净利息费用

872

900

最近的会计声明

偶尔,由财务会计准则委员会(“FASB”)和其他监管机构发布新的会计准则,这些准则将在指定的生效日期采纳。除非另有讨论,管理层认为,尚未生效的最近发布的准则对我们的合并财务报表在采纳后不会产生重大影响。在2025财年第一季度,没有采纳新的准则。

2023年11月,FASB发布了《2013-07号会计准则更新》,即《关于报告性部门披露的改进》(ASU 2023-07),该更新要求按部门披露重大费用,并要求揭示此前要求的年度披露项的中期披露。ASU 2023-07要求按照追溯制度应用,并于2023年12月15日后开始的财年和2024年12月15日后开始的财年内的中期披露中生效,允许提前采纳。我们正在评估ASU 2023-07对我们合并财务报表中披露的潜在影响。

2023年12月,FASB发布了《2013-09号会计准则更新》,即《关于所得税披露的改进》(ASU 2023-09),主要涉及额外披露主要与所得税率调和和所得税支付有关。ASU 2023-09要求实体每年披露所得税率调和,使用金额和百分比,考虑到包括州和地方所得税、外国税收影响、税收抵免或不可抵税项目等多个调和项目类别。披露的调和项目受数量门槛限制,并按性质和司法管辖区分开。ASU 2023-09还要求向联邦、州和外国司法管辖区披露净所得税支付或获得的信息,以及按照各司法管辖区披露,受到5%的数量门槛限制。ASU 2023-09可以按照前瞻性或追溯性采纳,并于2024年12月15日后开始的财年生效,允许提前采纳。我们正在评估ASU 2023-09对我们合并财务报表中披露的潜在影响。

10

目录

2。业务组合

在会计准则编纂主题805下, 业务合并 (“ASC 805”),收购会计方法要求我们按收购之日的估计公允价值记录收购的资产减去收购所承担的负债。总估计收购价格超过所收购净资产的估计公允价值的任何部分都应记作商誉。此类估值要求管理层做出重要的估计和假设,尤其是对无形资产的估值和假设。对某些无形资产进行估值的重要估计包括但不限于来自并购客户的未来预期现金流、收购的技术、商品名称、使用寿命和贴现率。管理层对公允价值的估计基于假设,这些假设被认为是合理的,但本质上是不确定和不可预测的,因此,实际业绩可能与估计有所不同。在自收购之日起最长一年的公允价值计量期内,随着收购之日存在的其他信息的出现,我们可能会记录对收购的初步资产和承担的负债的调整。计量期结束后,任何后续调整均包含在收益中。

2025 财年业务收购

2024 年 9 月,我们(通过我们的安全部门)收购了 100一家提供关键军事、太空和监视解决方案的私人控股供应商普通股的百分比,价格约为美元76.0 百万,再加上最多 $24.0 百万美元的潜在或有对价。我们支付了 $75.5 交易结束时现金为百万美元,并记录的滞留负债为美元0.5 百万美元,预计将在本财政年度结束前支付。为本次收购支付的现金由我们的信贷额度借款融资。或有对价的收购日公允价值为 $9.7 百万美元,因此,加上收盘时支付的现金金额和滞留金额,总收购对价为美元85.7 百万美元,已分配给所购资产和承担负债的初步公允价值。收购总资产的初步收购日期公允价值为 $115.0 百万其中包括 $ 的应收账款29.8 百万美元,库存和其他流动资产5.9 百万美元,财产和设备7.0 百万,商誉为美元28.4 百万美元和其他无形资产43.9 百万。出于所得税的目的,本次业务收购确认的商誉不可扣除。其他无形资产包括美元的可摊销无形资产35.9 百万,摊还期为 710 年了 以及无限期的美元无形资产8.0 百万。初步收购日假设总负债的公允价值为 $29.3 百万,其中包括递延所得税负债 $8.4 百万美元,主要是由于收购其他无形资产而确认的。收购资产的初步估值、承担的负债和收购中的或有对价有待修订。如果有其他信息,我们可能会在可行的情况下尽快进一步修改初步的收购价格分配,但不得迟于收购之日起一年。该收购业务的收入为 $4.0 从收购之日起至2024年9月30日为百万美元。

2024 财年业务收购

2023 年 12 月,我们(通过我们的光电子和制造部门)以约美元的价格收购了一家私人合同制造商6.3 百万。此次收购的资金来自手头现金。出于所得税的目的,本次业务收购确认的商誉可以扣除。

2023 年 10 月,我们(通过我们的安全部门)以约美元的价格收购了一家私营的辐射探测技术提供商2.8 百万,再加上最多 $3.6 百万美元的潜在或有对价。此次收购的资金来自手头现金。出于所得税的目的,本次业务收购确认的商誉不可扣除。

11

Table of Contents

3. Balance Sheet Details

The following tables set forth details of selected balance sheet accounts (in thousands):

June 30, 

September 30, 

Accounts receivable, net

    

2024

    

2024

Accounts receivable

$

667,227

$

706,844

Less allowance for doubtful accounts

 

(19,072)

(19,234)

Total

$

648,155

$

687,610

June 30, 

September 30, 

Inventories

    

2024

    

2024

Raw materials

$

238,086

$

242,738

Work-in-process

 

66,910

86,425

Finished goods

 

92,943

126,867

Total

$

397,939

$

456,030

June 30, 

September 30, 

Property and equipment, net

    

2024

    

2024

Land

$

15,494

$

16,125

Buildings, civil works and improvements

 

48,552

53,166

Leasehold improvements

 

13,573

15,462

Equipment and tooling

 

146,819

150,072

Furniture and fixtures

 

3,348

3,409

Computer equipment

 

22,597

23,870

Computer software

 

29,195

29,710

Computer software implementation in process

6,514

6,015

Construction in process

 

6,986

10,153

Total

 

293,078

307,982

Less accumulated depreciation and amortization

 

(179,111)

(183,369)

Property and equipment, net

$

113,967

$

124,613

Depreciation and amortization expense for property and equipment was $4.9 million and $6.7 million , respectively, for the three months ended September 30, 2023 and 2024.

4. Goodwill and Intangible Assets

The changes in the carrying value of goodwill by segment for the three-month period ended September 30, 2024 were as follows (in thousands):

Optoelectronics

and

Security

Manufacturing

Healthcare

    

Division

    

Division

    

Division

    

Consolidated

Balance as of June 30, 2024

$

232,215

$

70,807

$

48,458

$

351,480

Goodwill acquired during the period (see Note 2)

 

28,372

28,372

Foreign currency translation adjustment

 

223

1,201

168

1,592

Balance as of September 30, 2024

$

260,810

$

72,008

$

48,626

$

381,444

12

Table of Contents

Intangible assets consisted of the following (in thousands):

June 30, 2024

September 30, 2024

Gross

Gross

Carrying

Accumulated

Intangibles

Carrying

Accumulated

Intangibles

    

Value

    

Amortization

    

Net

    

Value

    

Amortization

    

Net

Amortizable assets:

Software development costs

$

79,228

$

(10,646)

$

68,582

$

83,339

$

(11,353)

$

71,986

Patents

9,116

(3,861)

5,255

9,265

(3,975)

5,290

Developed technology

70,186

(45,740)

24,446

97,284

(47,801)

49,483

Customer relationships

51,113

(41,421)

9,692

42,901

(26,051)

16,850

Total amortizable assets

 

209,643

(101,668)

107,975

232,789

(89,180)

143,609

Non-amortizable assets:

Trademarks

 

31,554

31,554

39,613

39,613

Total intangible assets

$

241,197

$

(101,668)

$

139,529

$

272,402

$

(89,180)

$

183,222

During the three months ended September 30, 2024 intangible assets of $43.9 million were included in the business acquisition described in Note 2.

Amortization expense related to intangible assets was $4.7 and $4.8 million for the three months ended September 30, 2023 and 2024, respectively.

At September 30, 2024, the estimated future amortization expense for amortizable intangible assets was as follows (in thousands):

Fiscal Year

2025 (remaining 9 months)

    

$

15,814

2026

 

17,965

2027

 

16,356

2028

 

15,532

2029

13,533

Thereafter

 

64,409

Total

$

143,609

Software development costs for software products incurred before establishing technological feasibility are charged to operations. Software development costs incurred after establishing technological feasibility are capitalized on a product-by-product basis until the product is available for general release to customers at which time amortization begins. Annual amortization, charged to cost of goods sold, is the amount computed using the ratio that current revenues for a product bear to the total current and anticipated future revenues for that product. In the event that future revenues are not estimable, such costs are amortized on a straight-line basis over the remaining estimated economic life of the product. Amortizable assets that have not yet begun to be amortized are included in Thereafter in the table above. For the three months ended September 30, 2023 and 2024, we capitalized software development costs in the amounts of $4.0 million and $4.2 million, respectively.

5. Contract Assets and Liabilities

We enter into contracts to sell products and provide services, and we recognize contract assets and liabilities that arise from these transactions. We recognize revenue and corresponding accounts receivable according to ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). When we recognize revenue in advance of the point in time at which contracts give us the right to invoice a customer, we record this as unbilled revenue, which is included in accounts receivable, net, on the consolidated balance sheets. We may also receive consideration, per the terms of a contract, from customers prior to transferring control of goods to the customer. We record customer deposits as contract liabilities. Additionally, we may receive payments, most typically under service and warranty contracts, at the onset of the contract and before services have been performed. In such instances, we record a deferred revenue liability in either Other accrued expenses and current liabilities or Other long-term liabilities. We recognize these contract liabilities as sales after all revenue recognition criteria are met.

13

Table of Contents

The table below shows the balance of contract assets and liabilities as of June 30, 2024 and September 30, 2024, including the change between the periods. There were no substantial non-current contract assets for the periods presented.

Contract Assets (in thousands)

    

June 30, 

    

September 30, 

    

    

 

    

2024

    

2024

    

Change

    

% Change

 

Unbilled revenue (included in accounts receivable, net)

$

338,944

$

346,589

$

7,645

2

%

Contract Liabilities (in thousands)

    

June 30, 

    

September 30, 

    

    

 

    

2024

    

2024

    

Change

    

% Change

Advances from customers

$

53,431

$

63,996

$

10,565

20

%

Deferred revenue—current

 

46,855

56,880

10,025

21

%

Deferred revenue—long-term

 

22,809

23,750

941

4

%

Contract Assets. Contract assets increased by approximately $7.6 million due to $27.9 million from the business acquisition described in Note 2, partially offset by decreases in unbilled revenue primarily from the achievement of certain milestones in our Security division which gives us the right to invoice customers.

Remaining Performance Obligations. Remaining performance obligations related to ASC 606 represent the portion of the transaction price allocated to performance obligations under an original contract with a term greater than one year which are fully or partially unsatisfied at the end of the period. As of September 30, 2024, the portion of the transaction price allocated to remaining performance obligations was approximately $805.2 million. We expect to recognize revenue on approximately of the remaining performance obligations over the next 12 months, and the remainder is expected to be recognized thereafter. During the three months ended September 30, 2024, we recognized revenue of $32.5 million from contract liabilities existing at the beginning of the period.

Practical Expedients. In cases where we are responsible for shipping after the customer has obtained control of the goods, we have elected to treat the shipping activities as fulfillment activities rather than as separate performance obligations. Additionally, we have elected to capitalize the cost to obtain a contract only if the period of amortization would be longer than one year. We only give consideration to whether a customer agreement has a financing component if the period of time between transfer of goods and services and customer payment is greater than one year.

6. Leases

The components of operating lease expense were as follows (in thousands):

Three Months Ended September 30, 

    

2023

    

2024

Operating lease cost

$

2,805

$

2,813

Variable lease cost

265

194

Short-term lease cost

325

497

$

3,395

$

3,504

14

Table of Contents

Supplemental disclosures related to operating leases were as follows (in thousands):

    

Balance Sheet Category

    

June 30, 2024

    

September 30, 2024

Operating lease right of use (“ROU”) assets, net

 

Other assets

$

30,040

$

28,994

Operating lease liabilities, current portion

 

Other accrued expenses and current liabilities

$

9,706

$

9,745

Operating lease liabilities, long-term

 

Other long-term liabilities

21,127

20,042

Total operating lease liabilities

$

30,833

$

29,787

Weighted average remaining lease term

3.6 years

Weighted average discount rate

4.6

%

Supplemental cash flow information related to operating leases was as follows (in thousands):

    

Three Months Ended September 30, 

    

2023

    

2024

Cash paid for operating lease liabilities

$

2,994

$

2,895

ROU assets obtained in exchange for new lease obligations

 

1,791

252

Maturities of operating lease liabilities at September 30, 2024 were as follows (in thousands):

    

September 30, 2024

Less than one year

$

10,840

1 – 2 years

 

9,407

2 – 3 years

 

6,821

3 – 4 years

 

2,533

4 – 5 years

 

1,272

Thereafter

 

1,432

 

32,305

Less: imputed interest

 

(2,518)

Total lease liabilities

$

29,787

7. Restructuring and Other Charges

We endeavor to align our global capacity and infrastructure with demand by our customers and to effectively integrate acquisitions and thereby improve our operational efficiency.

During the three months ended September 30, 2024, we recognized $1.2 million in restructuring and other charges, which included $0.6 million for employee terminations, $0.2 million for facility closure costs for operational efficiency activities, and $0.4 million in acquisition related costs.

During the three months ended September 30, 2023, we recognized $0.5 million in restructuring and other charges, which included $0.1 million in legal charges, $0.1 million for employee terminations, $0.1 million for facility closure costs for operational efficiency activities, and $0.2 million in acquisition related costs.

15

Table of Contents

The following tables summarize restructuring and other charges for the periods set forth below (in thousands):

Three Months Ended September 30, 2023

    

    

Optoelectronics and

    

    

    

Manufacturing

Healthcare

    

Security Division

    

Division

    

Division

    

Corporate

    

Total

Acquisition-related costs

$

208

$

$

$

$

208

Employee termination costs

13

110

123

Facility closures/consolidation

 

51

51

Legal costs, net

 

52

32

84

Total

$

273

$

51

$

$

142

$

466

Three Months Ended September 30, 2024

Optoelectronics and

Manufacturing

Healthcare

    

Security Division

    

Division

    

Division

    

Corporate

    

Total

Acquisition-related costs

$

350

$

$

$

$

350

Employee termination costs

123

304

152

579

Facility closures/consolidation

6

243

249

Total

$

479

$

547

$

152

$

$

1,178

The accrued liability for restructuring and other charges is included in Other accrued expenses and current liabilities in the condensed consolidated balance sheets. The changes in the accrued liability for restructuring and other charges for the three-month period ended September 30, 2024 were as follows (in thousands):

Facility

Acquisition-

Employee

Closure/

Legal

Related 

Termination

Consolidation

Costs and

    

Costs

    

Costs

    

Cost

    

Settlements

    

Total

Balance as of June 30, 2024

$

496

$

294

$

227

$

808

$

1,825

Restructuring and other charges, net

 

350

579

249

 

1,178

Payments, adjustments and reimbursements, net

 

(503)

(762)

(276)

 

(4)

(1,545)

Balance as of September 30, 2024

$

343

$

111

$

200

$

804

$

1,458

8. Borrowings

Revolving Credit Facility

Our senior secured credit facility comprises a term loan and a $600 million revolving credit facility which mature in December 2026. The revolving credit facility includes a $300 million sub-limit for letters of credit. Under certain circumstances and subject to certain conditions, we have the ability to increase the revolving credit facility by an amount equal to the greater of $250 million or such amount as would not cause our secured leverage ratio to exceed a specified level. Borrowings under the facility bore interest at SOFR plus a margin of 1.25% as of September 30, 2024 (which margin can range from 1.0% to 1.75% based on our consolidated net leverage ratio as defined in the credit facility). Letters of credit reduce the amount available to borrow under the credit facility by their face value amount. The unused portion of the facility bore a commitment fee of 0.15% as of September 30, 2024 (which fee can range from 0.10% to 0.25% based on our consolidated net leverage ratio as defined in the credit facility). Our borrowings under the credit agreement are guaranteed by certain of our U.S.-based subsidiaries and are secured by substantially all of our assets and substantially all the assets of certain of our subsidiaries. The credit facility contains various representations and warranties, affirmative, negative and financial covenants and events of default. As of September 30, 2024, there were $259.0 million of borrowings outstanding under the revolving credit facility, $77.1 million outstanding under the letters of credit sub-facility, and $133.8 million outstanding under the term loan. As of September 30, 2024, the amount available to borrow under the revolving credit facility was $263.9 million. Loan amounts under the revolving credit facility may be borrowed, repaid and re-borrowed during the term. The principal amount of each loan is due and payable in full on the maturity date. We have the right to repay each loan in whole or in part from time to time without penalty. It is our practice to routinely borrow and repay several times per year under the revolving facility and therefore, borrowings under the revolving credit facility are included in current liabilities. As of September 30, 2024, we were in compliance with all financial covenants under this credit facility. In September 2022, we entered into an interest rate swap in order to mitigate the interest rate risk on a portion of the interest payments expected to be made on the borrowings outstanding under the revolving credit facility and term loan. Refer to Note 1 for details.

16

Table of Contents

2.25% Convertible Senior Notes Due 2029

In July 2024, we issued an aggregate of $350.0 million principal amount of 2.25% convertible senior notes due in August 2029 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, at an issuance price equal to 97.5% of the principal amount. The 2029 Notes were issued pursuant to and are governed by an indenture dated July 19, 2024 The proceeds from the issuance of the 2029 Notes were $340.4 million, net of the issuance discount and debt issuance costs.

The 2029 Notes are unsecured obligations which bear regular interest at 2.25% per annum payable semiannually in arrears on February 1 and August 1 of each year, beginning on February 1, 2025. The 2029 Notes will mature on August 1, 2029, unless repurchased, redeemed, or converted in accordance with their terms prior to such date. The 2029 Notes are convertible into a combination of cash and shares of our common stock, at an initial conversion rate of 5.2090 shares of common stock per $1,000 principal amount of 2029 Notes, which is equivalent to an initial conversion price of approximately $191.98 per share of our common stock. The default settlement method is a combination settlement with a specified dollar amount of $1,000 per $1,000 principal amount of notes. The conversion rate is subject to customary adjustments for certain dilutive events. We may redeem for cash all or any portion of the 2029 Notes, at our option, on or after August 6, 2027 if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days at a redemption price equal to 100% of the principal amount of the 2029 Notes to be redeemed, plus accrued and unpaid interest up to the day before the redemption date. The holders may require us to repurchase the 2029 Notes upon the occurrence of certain fundamental change transactions at a redemption price equal to 100% of the principal amount of the 2029 Notes redeemed, plus accrued and unpaid interest up to the day before the redemption date.

Holders of the 2029 Notes may convert all or a portion of their 2029 Notes at their option prior to May 1, 2029, in multiples of $1,000 principal amounts, only under the following circumstances (i) during any calendar quarter commencing after the quarter ended on September 30, 2024 (and only during such calendar quarter), if our common stock price exceeds 130% of the conversion price for at least 20 trading days during the 30 consecutive trading days at the end of the prior calendar quarter; (ii) during the five consecutive business days immediately after any 10 consecutive trading day period in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (iii) upon the occurrence of specified corporate events or certain distributions on our common stock; or (iv) if we call any or all 2029 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the notes called for redemption.

On or after May 1, 2029, the 2029 Notes are convertible at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. Holders of the 2029 Notes who convert the 2029 Notes in connection with a make-whole fundamental change, as defined in the indenture governing the 2029 Notes, or in connection with a redemption may be entitled to an increase in the conversion rate.

We accounted for the issuance of the 2029 Notes as a single liability measured at its amortized cost, as no other embedded features require bifurcation and recognition as derivatives. The following table is a summary of the 2029 Notes as of September 30, 2024 (in thousands):

    

September 30,

2024

Principal amount

$

350,000

Unamortized debt discount and issuance costs

 

(9,201)

Net carrying amount

$

340,799

Fair value (Level 2)

$

363,552

The 2029 Notes were not eligible for conversion as of September 30, 2024. No sinking fund is provided for the 2029 Notes, which means that we are not required to redeem or retire them periodically. As of September 30, 2024 we were in compliance with applicable covenants under the indenture governing the 2029 Notes.

For the three months ended September 30, 2024, total interest expense for the 2029 Notes was $1.9 million, which consisted of $1.6 million of contractual interest expense and $0.3 million of amortization of debt discount and issuance costs. The unamortized debt issuance cost is amortized on the effective interest method over the life of the 2029 Notes.

17

Table of Contents

Other Borrowings

Several of our foreign subsidiaries maintain bank lines of credit, denominated in local currencies and U.S. dollars, primarily for the issuance of letters of credit. As of September 30, 2024, $55.9 million was outstanding under these letter-of-credit facilities. As of September 30, 2024, the total amount available under these credit facilities was $30.3 million.

Long-term debt consisted of the following (in thousands):

    

June 30, 

September 30, 

    

2024

    

2024

Term loan

$

135,625

$

133,750

2029 Notes, net

340,799

Other long-term debt

 

1,925

1,752

 

137,550

476,301

Less current portion of long-term debt

 

(8,167)

(8,217)

Long-term portion of debt

$

129,383

$

468,084

Future principal payments of long-term debt by fiscal year as of September 30, 2024 are as follows (in thousands):

2025 (9 months remaining)

    

$

6,137

2026

 

8,157

2027

 

121,058

2028

 

147

2029 and thereafter

 

340,802

Total

$

476,301

9. Stockholders’ Equity

Stock-based Compensation

As of September 30, 2024, we maintained the Amended and Restated 2012 Incentive Award Plan (the “OSI Plan”) as a stock-based employee compensation plan.

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

Three Months Ended September 30, 

    

2023

    

2024

Cost of goods sold

$

232

$

244

Selling, general and administrative

6,731

6,024

Research and development

126

154

Stock-based compensation expense

$

7,089

$

6,422

As of September 30, 2024, total unrecognized compensation cost related to share-based compensation grants under the OSI Plan were estimated at $0.7 million for stock options and $18.4 million for restricted stock units (“RSUs”). We expect to recognize these costs over a weighted average period of 1.8 years with respect to the stock options and 2.3 years with respect to the RSUs.

18

Table of Contents

The following summarizes stock option activity during the three months ended September 30, 2024:

Weighted

Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2024

 

78,958

 

$

97.87

 

Granted

 

Exercised

 

(957)

69.64

Expired or forfeited

 

Outstanding at September 30, 2024

 

78,001

$

105.17

7.4 years

$

4,182

Exercisable at September 30, 2024

33,690

$

89.06

 

6.0 years

$

2,115

The following summarizes RSU award activity during the three months ended September 30, 2024:

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2024

 

391,591

$

99.21

Granted

 

253,256

95.41

Vested

 

(297,418)

130.64

Forfeited

 

(2,400)

98.75

Nonvested at September 30, 2024

 

345,029

$

106.76

As of September 30, 2024, there were approximately 2.1 million shares available for grant under the OSI Plan. Under the terms of the OSI Plan, RSUs granted from the pool of shares available for grant reduce the pool by 1.87 shares for each award granted. RSUs forfeited and returned to the pool of shares available for grant increase the pool by 1.87 shares for each award forfeited.

We granted 75,988 and 54,563 performance-based RSUs during the three months ended September 30, 2023 and 2024, respectively. These performance-based RSU awards are contingent on the achievement of certain performance metrics. The payout related to these awards can range from zero to 376% of the original number of shares or units awarded. Compensation cost associated with these performance based RSUs are recognized based on the estimated number of shares that we ultimately expect will vest. If the estimated number of shares to vest is revised in the future, then stock-based compensation expense will be adjusted accordingly.

Stock Repurchase Program

In September 2022, our Board of Directors increased the stock repurchase authorization to a total of 2 million shares. This program does not expire unless our Board of Directors acts to terminate the program. The timing and actual numbers of shares purchased depends on a variety of factors, including stock price, general business and market conditions and other investment opportunities. Repurchases may be made from time to time under the program through open-market purchases or privately-negotiated transactions at our discretion. Upon repurchase, the shares are restored to the status of authorized but unissued shares, and we record them in our consolidated financial statements as a reduction in the number of shares of common stock issued and outstanding, with the excess purchase price over par value recorded as a reduction of additional paid-in capital. If additional paid-in capital is reduced to zero, we record the remainder of the excess purchase price over par value as a reduction of retained earnings.

During the three months ended September 30, 2024, we repurchased 531,314 shares of common stock for an aggregate purchase price of approximately $80 million. As of September 30, 2024, there were 1,190,556 shares remaining available for repurchase under the authorized repurchase program.

Dividends

We have not paid any dividends since the consummation of our initial public offering in 1997 and we do not currently intend to pay any dividends in the foreseeable future. Our Board of Directors will determine the payment of future dividends, if any. Certain of our current bank credit facilities restrict the payment of dividends and future borrowings may contain similar restrictions.

19

Table of Contents

10. Commitments and Contingencies

Acquisition-Related Contingent Obligations

Under the terms and conditions of the purchase agreements associated with certain acquisitions, we may be obligated to make additional payments based on the achievement of certain sales or profitability milestones through the acquired operations. For agreements that contain contingent consideration obligations that are capped, the remaining maximum amount of such potential future payments is $56.8 million as of September 30, 2024.

Projections and estimated probabilities are used to estimate future contingent earnout payments, which are discounted back to present value to compute contingent earnout liabilities. The following table provides a roll-forward from June 30, 2024 to September 30, 2024 of the contingent consideration liability, which is included in Other accrued expenses and current liabilities and other long-term liabilities in our consolidated balance sheets (in thousands):

Beginning fair value, June 30, 2024

    

$

15,375

Business acquisition (Note 2)

9,730

Foreign currency translation adjustment

188

Changes in fair value for contingent earnout obligations

 

(716)

Payments on contingent earnout obligations

 

(331)

Ending fair value, September 30, 2024

$

24,246

Environmental Contingencies

We are subject to various environmental laws. We conduct environmental investigations at our manufacturing facilities in North America, Asia-Pacific, and Europe, and, to the extent practicable, on all new properties in order to identify, as of the date of such investigation, potential areas of environmental concern related to past and present activities or from nearby operations. In certain cases, we have conducted further environmental assessments consisting of soil and groundwater testing and other investigations deemed appropriate by independent environmental consultants.

We have not accrued for loss contingencies relating to environmental matters because we believe that, although unfavorable outcomes are possible, they are not considered by our management to be probable and reasonably estimable. If one or more of these environmental matters are resolved in a manner adverse to us, the impact on our business, financial condition, results of operations and cash flow could be material.

Indemnifications and Certain Employment-Related Contingencies

In the normal course of business, we have agreed to indemnify certain parties with respect to certain matters. We have agreed to hold certain parties harmless against losses arising from a breach of representations, warranties or covenants, or intellectual property infringement or other claims made by third parties. These agreements may limit the time within which an indemnification claim can be made and the amount of the claim. In addition, we have entered into indemnification agreements with our directors and certain of our officers. It is not possible to determine the maximum potential amount under these indemnification agreements due to, among other factors, the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. We have not recorded any liability for costs related to contingent indemnification obligations as of September 30, 2024.

Product Warranties

We offer our customers warranties on many of the products that we sell. These warranties typically provide for repairs and maintenance of the products if problems arise during a specified time period after original shipment. Concurrent with the sale of products, we record a provision for estimated warranty expenses with a corresponding increase in cost of goods sold. We periodically adjust this provision based on historical experience and anticipated expenses. We charge actual expenses of repairs under warranty, including parts and labor, to this provision when incurred. The current obligation for warranty provision is included in other accrued expenses and current liabilities and the noncurrent portion is included in other long-term liabilities in the consolidated balance sheets.

20

Table of Contents

The following table presents changes in warranty provisions (in thousands):

Three Months Ended September 30, 

    

2023

    

2024

Balance at beginning of period

$

11,149

$

11,089

Additions

312

988

Reductions for warranty repair costs and adjustments

 

(902)

(719)

Balance at end of period

$

10,559

$

11,358

Legal Proceedings

In February 2023, one of our subsidiaries received a subpoena from the U.S. Department of Justice (“DoJ”). The subpoena was issued as part of a DoJ case against a former employee of an OSI Systems subsidiary for embezzlement and other conduct occurring before he was hired by our subsidiary and while he was employed by another company in the United States and Mexico. The subpoena requests documents and records relating to, among other things, the former employee and the Company’s business dealings in Mexico since 2020. In February 2024, we received a follow-up subpoena requesting the same categories of documents but extending the relevant time period through to the date of the second subpoena. We have produced documents in response to these subpoenas and intend to cooperate with any further subpoenas or other requests in connection with this or any ensuing investigation. In September 2024, we received a subpoena requesting records relating to certain entities in Honduras. Consistent with past practice, we intend to cooperate with requests arising from this most recent subpoena.

We are involved in various other potential or actual claims and legal proceedings arising in the ordinary course of business. In our opinion after consultation with legal counsel, the ultimate disposition of such proceedings is not likely to have a material adverse effect on our business, financial condition, results of operations or cash flows. We have not accrued for loss contingencies relating to any non-ordinary course matters because we believe that, although unfavorable outcomes in the proceedings are possible, they are not considered by management to be probable and reasonably estimable. If one or more of these matters are resolved in a manner adverse to our Company, the impact on our business, financial condition, results of operations and cash flows could be material.

11. Income Taxes

The determination of the annual effective tax rate is based upon a number of significant estimates and judgments, including the estimated annual pretax income in each tax jurisdiction in which we operate and the development of tax planning strategies during the year. In addition, as a global commercial enterprise, our tax expense can be impacted by changes in tax rates or laws, the finalization of tax audits and reviews and other factors that cannot be predicted with certainty. As such, there can be significant volatility in interim tax provisions.

The effective tax rates for the three months ended September 30, 2023 and 2024 were 23.4% and 21.9%, respectively. During the three months ended September 30, 2023 and 2024, we recognized a net discrete tax benefit of $0.4 million and $0.5 million, respectively, related to equity-based compensation under ASU 2016-09.

21

Table of Contents

12. Segment Information

We have determined that we operate in three identifiable industry segments: (a) security and inspection systems (Security division), (b) optoelectronic devices and manufacturing (Optoelectronics and Manufacturing division) and (c) medical monitoring systems (Healthcare division). We also have a corporate segment (Corporate) that includes executive compensation and certain other general and administrative expenses, expenses related to stock issuances and legal, audit and other professional service fees not allocated to industry segments. Both the Security and Healthcare divisions comprise primarily end-product businesses, whereas the Optoelectronics and Manufacturing division primarily supplies components and subsystems to external OEM customers, as well as to the Security and Healthcare divisions. Sales between divisions are at transfer prices that approximate market values. All other accounting policies of the segments are the same as described in Note 1, Basis of Presentation.

The following tables present our results of operations and identifiable assets by industry segment (in thousands):

Three Months Ended

September 30, 

    

2023

    

2024

Revenues (1) —by Segment:

Security division

$

164,629

$

224,314

Optoelectronics and Manufacturing division, including intersegment revenues

96,128

97,795

Healthcare division

37,787

37,102

Intersegment revenues elimination

(19,334)

(15,204)

Total

$

279,210

$

344,007

Income (loss) from operations —by Segment:

Security division

$

20,609

$

28,856

Optoelectronics and Manufacturing division

11,437

10,609

Healthcare division

164

800

Corporate

(9,916)

(9,510)

Intersegment Eliminations

265

(427)

Total

$

22,559

$

30,328

June 30, 

September 30, 

    

2024

    

2024

Assets (2) —by Segment:

Security division

$

1,333,259

$

1,514,264

Optoelectronics and Manufacturing division

 

288,629

289,302

Healthcare division

255,093

255,639

Corporate

 

106,078

100,958

Eliminations (3)

 

(47,051)

(46,649)

Total

$

1,936,008

$

2,113,514

(1)For the three months ended September 30, 2023, no customer accounted for greater than 10% of total net revenues. For the three months ended September 30, 2024, one Security division customer accounted for 14% of net revenues.
(2)As of June 30, 2024, two customers in the Security division accounted for 39% and 10%, respectively, of accounts receivable, net. As of September 30, 2024, two customers in the Security division accounted for 37% and 12%, respectively, of accounts receivable, net.
(3)Eliminations in assets reflect the amount of inter-segment profits in inventory and inter-segment ROU assets under ASC 842 as of the balance sheet date. Such inter-segment profit will be realized when inventory is shipped to the external customers of the Security and Healthcare divisions.

22

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

In this report, “OSI”, the “Company”, “we”, “us”, “our” and similar terms refer to OSI Systems, Inc. together with our wholly-owned subsidiaries.

This management’s discussion and analysis of financial condition as of September 30, 2024 and results of operations for the three months ended September 30, 2024 should be read in conjunction with management’s discussion and analysis of financial condition and results of operations included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024 filed with the SEC.

Forward-Looking Statements

This report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements relate to our current expectations, beliefs, and projections concerning matters that are not historical facts. Words such as “project,” “believe,” “anticipate,” “plan,” “expect,” “intend,” “may,” “should,” “will,” “would,” and similar words and expressions are intended to identify forward-looking statements. Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions and contingencies, many of which are outside our control. Assumptions upon which our forward-looking statements are based could prove to be inaccurate, and actual results may differ materially from those expressed in or implied by such forward-looking statements. Important factors that could cause our actual results to differ materially from our expectations are disclosed in this report, our Annual Report on Form 10-K for the fiscal year ended June 30, 2024 (including Part I, Item 1, “Business,” Part I, Item 1A, “Risk Factors” and Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations”) and other documents filed by us from time to time with the SEC. Such factors, of course, do not include all factors that might affect our business and financial condition. We could be exposed to a variety of negative consequences as a result of delays related to the award of domestic and international contracts; failure to secure the renewal of key customer contracts; delays in customer programs; delays in revenue recognition related to the timing of customer acceptance; the impact of potential information technology, cybersecurity or data security breaches; changes in domestic and foreign government spending, budgetary, procurement and trade policies adverse to our businesses; the impact of the Russia-Ukraine conflict or conflicts in the Middle East, including the potential for broad economic disruption; global economic uncertainty; material delays and cancellations of orders or deliveries thereon, supply chain disruptions, plant closures, or other adverse impacts on our ability to execute business plans; unfavorable currency exchange rate fluctuations; effect of changes in tax legislation; market acceptance of our new and existing technologies, products and services; our ability to win new business and convert any orders received to sales within the fiscal year; contract and regulatory compliance matters, and actions, which if brought, could result in judgments, settlements, fines, injunctions, debarment or penalties; as well as other risks and uncertainties, including but not limited to those factors described in our other SEC filings. All forward-looking statements contained in this report are qualified in their entirety by this Section. Moreover, we operate in a very competitive and rapidly changing environment and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Investors should not place undue reliance on forward-looking statements as a prediction of actual results. We undertake no obligation other than as may be required under securities laws to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Executive Summary

We are a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications. We sell our products and provide related services in diversified markets, including homeland security, healthcare, defense and aerospace. We have three operating divisions: (a) Security, providing security and inspection systems and turnkey security screening solutions; (b) Optoelectronics and Manufacturing, providing specialized electronic components for our Security and Healthcare divisions, as well as to third parties for applications in the defense and aerospace markets, among others; and (c) Healthcare, providing patient monitoring, cardiology and remote monitoring, and connected care systems and associated accessories.

Security Division. Security and inspection products are used in airports and at a wide range of other facilities such as border crossings, seaports, freight forwarding operations (to screen cargo before it is loaded onto airplanes and ships), government and military installations, sports and concert venues, correctional facilities, and other locations where the interdiction of criminal activities is paramount. The U.S. Department of Homeland Security has undertaken numerous initiatives to prevent terrorists from entering the

23

Table of Contents

country, hijacking airplanes, and obtaining and transporting explosives, weapons and their components, and to prevent human trafficking, among other serious crimes. These initiatives, such as the Customs-Trade Partnership Against Terrorism, the U.S. Transportation Security Administration’s Air Cargo Screening Mandate and the U.S. Customs and Border Protection Container Security Initiative, have resulted in increased demand for security and inspection products, as have similar programs undertaken by governments around the world. Revenues from our Security division accounted for 59% and 65% of our total consolidated revenues for the three months ended September 30, 2023 and 2024, respectively.

Optoelectronics and Manufacturing Division. Through our Optoelectronics and Manufacturing division, we design, manufacture and market optoelectronic devices and flex circuits and provide electronics manufacturing services globally for use in a broad range of applications, including aerospace and defense electronics, security and inspection systems, medical imaging and diagnostics, telecommunications, office automation, computer peripherals, industrial automation and consumer products. We also provide our optoelectronic devices and electronics manufacturing services to OEM customers and to our own Security and Healthcare divisions. Revenues from external customers in our Optoelectronics and Manufacturing division accounted for 28% and 24% of our total consolidated revenues for the three months ended September 30, 2023 and 2024, respectively.

Healthcare Division. Through our Healthcare division, we design, manufacture, market and service patient monitoring, cardiology and remote monitoring, and connected care systems globally for sale primarily to hospitals and medical centers. Our products monitor patients in critical, emergency and perioperative care areas of the hospital and provide information, through wired and wireless networks, to physicians and nurses who may be at the patient’s bedside, in another area of the hospital or even outside the hospital. Revenues from our Healthcare division accounted for 13% and 11% of our total consolidated revenues for the three months ended September 30, 2023 and 2024, respectively.

Trends and Uncertainties

The following is a discussion of certain trends and uncertainties that we believe have influenced, and may continue to influence, our results of operations.

Global Economic Considerations. Our products and services are sold in numerous countries worldwide, with a large percentage of our sales generated outside the United States. We are exposed to and impacted by global macroeconomic factors, U.S. and foreign government policies and foreign exchange fluctuations. There is uncertainty surrounding macroeconomic factors in the U.S. and globally characterized by supply chain disruptions, inflationary pressure, and labor shortages. Increasing diplomatic and trade friction between the U.S. and China has also created significant uncertainty in the global economy. These global macroeconomic factors, coupled with political unrest internationally and the volatile U.S. political climate, including uncertainty regarding the upcoming U.S. presidential election, have created uncertainty and impacted demand for certain of our products and services. Conflicts in Gaza and nearby regions have created political and economic uncertainty in the Middle East. Also, the continued conflict between Russia and Ukraine and the sanctions imposed in response to this conflict have increased global economic and political uncertainty. We do not know how long this uncertainty will continue. These factors could have a material adverse effect on our business, results of operations and financial condition.

Global Trade. The current domestic and international political environment, including in relation to recent and further potential changes by the U.S. and other countries in policies on global trade and tariffs, have resulted in uncertainty surrounding the future state of the global economy and global trade. This uncertainty is exacerbated by sanctions imposed by the U.S. government against certain businesses and individuals in select countries. Continued or increased uncertainty regarding global trade due to these or other factors may require us to modify our current business practices and could have a material adverse effect on our business, results of operations and financial condition.

Healthcare Considerations. Our Healthcare division experienced some increased demand for its patient monitoring products as a result of the COVID-19 pandemic during the earlier stages of the pandemic. Certain hospitals are facing significant financial pressure as supply chain constraints and inflation drive up operating costs, and higher interest rates make access to credit more expensive. Continuation of these macroeconomic conditions would likely have an adverse impact on hospitals’ spend on capital equipment and thereby could have a material adverse effect on our business, results of operations and financial condition.

Government Policies. Our results of operations and cash flows could be materially affected by changes in U.S. or foreign government legislative, regulatory or enforcement policies.

24

Table of Contents

Russia’s Invasion of Ukraine. The invasion of Ukraine by Russia and the sanctions imposed in response to this conflict have increased global economic and political uncertainty. This has the potential to indirectly disrupt our supply chain and access to certain resources. While we have not experienced significant adverse impacts to date and will continue to monitor for any impacts and seek to mitigate disruption that may arise, we have certain research and development activities within Ukraine for our Healthcare division which have been somewhat impacted. The conflict also has increased the threat of malicious cyber activity from nation states and other actors.

Currency Exchange Rates. On a year-over-year basis, currency exchange rates negatively impacted reported sales by approximately 0.7% for the three months ended September 30, 2024 compared to the three months ended September 30, 2023, primarily due to the strengthening of the U.S. dollar against other foreign currencies in 2024. Any further strengthening of the U.S. dollar against foreign currencies would adversely impact our sales for the remainder of the fiscal year, and any weakening of the U.S. dollar against foreign currencies would positively impact our sales for the remainder of the fiscal year.

Results of Operations for the Three Months Ended September 30, 2023 (Q1 Fiscal 2024) Compared to the Three Months Ended September 30, 2024 (Q1 Fiscal 2025) (amounts in millions)

Net Revenues

The table below and the discussion that follows are based upon the way in which we analyze our business. See Note 12 to the condensed consolidated financial statements for additional information about our business segments.

    

Q1

    

% of

    

Q1

    

% of

    

    

 

    

Fiscal 2024

    

Net Revenues

    

Fiscal 2025

    

Net Revenues

    

$ Change

    

% Change

 

Security

 

$

164.6

59.0

%

$

224.3

65.2

%

$

59.7

36.3

%

Optoelectronics and Manufacturing

76.8

27.5

82.6

24.0

5.8

7.6

Healthcare

37.8

13.5

37.1

10.8

(0.7)

(1.9)

Total net revenues

 

$

279.2

100

%

$

344.0

100.0

%

$

64.8

23.2

%

Revenues for the Security division during Q1 fiscal 2025 increased year-over-year due to increases in product and service revenues of approximately $52.1 million and $7.6 million, respectively. The increase in product revenues was primarily driven by growth in cargo and vehicle inspection systems, trace detections systems, checkpoint screening sales, and the acquired business further described in Note 2 to the condensed consolidated financial statements. The increase in service revenue was due primarily to an increase in the installed base of products.

Revenues for the Optoelectronics and Manufacturing division during Q1 fiscal 2025 increased year-over-year as a result of an increase in revenues in our contract manufacturing business of approximately $7.4 million, offset by a decrease in revenues in our optoelectronics business of approximately $1.6 million.

Revenues for the Healthcare division during Q1 fiscal 2025 decreased year-over-year due to lower product sales of $2.2 million, partially offset by an increase in service revenues of $1.5 million.

25

Table of Contents

Gross Profit

Q1

% of

Q1

% of

    

Fiscal 2024

    

Net Revenues

    

Fiscal 2025

    

Net Revenues

    

Gross profit

$

98.7

35.4

%

$

121.5

35.3

%

Gross profit is impacted by sales volume and changes in overall manufacturing-related costs, such as raw materials and component costs, warranty expense, provision for inventory, freight, and logistics. Gross profit increased approximately $22.8 million in Q1 fiscal 2025 as compared to the prior year driven by the increase in sales. Our cost of goods sold increased year-over-year primarily as a result of the increase in revenues.

Operating Expenses

Q1

    

% of

    

Q1

% of

    

Fiscal 2024

    

Net Revenues

    

Fiscal 2025

    

Net Revenues

    

$ Change

    

% Change

Selling, general and administrative

    

$

59.8

    

21.4

%  

$

72.2

21.0

%  

$

12.4

20.7

%

Research and development

 

15.9

 

5.7

17.8

5.2

 

1.9

11.9

Impairment, restructuring and other charges, net

 

0.5

 

0.2

1.2

0.3

 

0.7

140.0

Total operating expenses

$

76.2

 

27.3

%  

$

91.2

26.5

%  

$

15.0

19.7

%

Selling, general and administrative. Our significant selling, general and administrative (“SG&A”) expenses include employee compensation, sales commissions, travel, professional services, marketing expenses, foreign currency translation, and depreciation and amortization expense. SG&A expense for Q1 fiscal 2025 was $12.4 million higher than in the same prior-year period primarily due to unfavorable foreign currency exchange rates and an increase in employee compensation in Q1 fiscal 2025 to support the growth of the Company as compared to the same prior-year period.

Research and development. Research and development (“R&D”) expenses include research related to new product development and product enhancements. R&D expenses increased $1.9 million in Q1 fiscal 2025 as compared to Q1 fiscal 2024 driven by increased compensation costs to support new product development initiatives primarily in our Security division.

Restructuring and other charges. Restructuring and other charges generally consist of costs relating to reductions in our workforce, facilities consolidation, costs related to acquisition activity, and other non-recurring charges. During Q1 fiscal 2025, restructuring and other charges consisted of $0.4 million for acquisition activity and $0.8 million related to employee terminations, and legal and other costs. During Q1 fiscal 2024, restructuring and other charges consisted of $0.2 million for acquisition activity and $0.3 million related to employee terminations, and legal and other costs.

Interest and Other Expense, Net

Q1

% of

Q1

% of

 

    

Fiscal 2024

    

Net Revenues

    

Fiscal 2025

    

Net Revenues

 

Interest and other expense, net

$

5.7

 

2.0

%  

$

7.4

 

2.2

%

Interest and other expense, net. For Q1 fiscal 2025, interest and other expense, net was $7.4 million as compared to $5.7 million in the same prior-year period. This increase was driven by higher average levels of borrowings primarily to support the increase in working capital associated with the growth in revenues and for the repurchase of approximately $80 million of common stock in July 2024.

Income taxes. The effective tax rate for a particular period varies depending on a number of factors, including (i) the mix of income earned in various tax jurisdictions, each of which applies a unique range of income tax rates and income tax credits, (ii) changes in previously established valuation allowances for deferred tax assets (changes are based upon our current analysis of the likelihood that these deferred tax assets will be realized), (iii) the level of non-deductible expenses, (iv) certain tax elections (v) tax holidays granted to certain of our international subsidiaries and (vi) discrete tax items. For Q1 fiscal 2025 and 2024, we recognized a provision for income taxes of $5.0 million and $3.9 million, respectively. The effective tax rates for Q1 fiscal 2025 and 2024 were 21.9% and 23.4%, respectively. During Q1 fiscal 2025 and 2024, we recognized a net discrete tax benefit of $0.5 million and $0.4 million, respectively, related to equity-based compensation under ASU 2016-09.

26

Table of Contents

Liquidity and Capital Resources

Our principal sources of liquidity are our cash and cash equivalents, cash generated from operations and our credit facilities. Cash and cash equivalents totaled $85.1 million at September 30, 2024, a decrease of $10.3 million, or 11%, from $95.4 million at June 30, 2024. We currently anticipate that our available funds, credit facilities and cash flow from operations will be sufficient to meet our operational cash needs for the next 12 months and the foreseeable future beyond that. In addition, we anticipate that cash generated from operations, without repatriating earnings from our non-U.S. subsidiaries, and our credit facilities will be sufficient to satisfy our obligations in the U.S.

In July 2024, we issued an aggregate of $350.0 million principal amount of 2.25% convertible senior notes due in August 2029 In connection with the issuance of the 2029 Notes, we repurchased 531,314 shares of our common stock for approximately $80 million.

Our credit facility comprises a term loan and a $600 million revolving credit facility, which includes a $300 million sub-facility for letters of credit. As of September 30, 2024, there was $133.8 million outstanding under the term loan, $259.0 million outstanding under our revolving credit facility and $77.1 million of outstanding letters of credit. As of September 30, 2024, the total amount available under our revolving credit facility was $263.9 million. See Note 8 to the consolidated financial statements for further discussion.

Cash Provided by (Used in) Operating Activities. Cash flows from operating activities can fluctuate significantly from period to period, as net income, adjusted for non-cash items, and working capital fluctuations impact cash flows. During Q1 fiscal 2025, we used cash from operations of $37.2 million compared to cash provided by operations of $17.1 million in the comparable prior-year period. The net change in cash flows from operating activities was due primarily to a net increase in accounts receivable, inventories and other current assets in the Security division, partially offset by other changes in net working capital.

Cash Used in Investing Activities. Net cash used in investing activities was $87.5 million for Q1 fiscal 2025 as compared to $9.6 million in the same prior-year period. We used $75.5 million for a business acquisition during the three-month period ended September 30, 2024. Capital expenditures in the three-month period ended September 30, 2024 were $7.7 million compared to $5.2 million in the same prior-year period. Expenditures for intangible and other assets in the three-month period ended September 30, 2024 were $4.4 million compared to $4.2 million in the same prior-year period.

Cash Used in Financing Activities. Net cash provided by financing activities was $113.8 million during Q1 fiscal 2025, compared to $1.9 million used during the same prior-year period. The change in cash flows from financing activities was primarily due to net proceeds of $340.4 million from the 2029 Notes, partially offset by (1) net repayment of $125.0 million on our credit facility and (2) repurchase of common shares of $80.4 million. Taxes paid related to net share settlement of equity awards was $21.3 million during Q1 fiscal 2025 compared to $22.2 million in the same prior-year period.

Borrowings

See Note 8 to the condensed consolidated financial statements for a detailed discussion regarding our revolving credit facility and other borrowings.

Cash Held by Foreign Subsidiaries

Our cash and cash equivalents totaled $85.1 million at September 30, 2024. Of this amount, approximately 81% was held by our foreign subsidiaries and subject to repatriation tax considerations. These foreign funds were held primarily by our subsidiaries in the, India, UK, Singapore, Canada and Malaysia and to a lesser extent in Mexico, Egypt, Indonesia, Albania, and Australia among other countries. We intend to permanently reinvest certain earnings from foreign operations, and we currently do not anticipate that we will need this cash in foreign countries to fund our U.S. operations. In the event we repatriate cash from certain foreign operations and if taxes have not previously been withheld on the related earnings, we would provide for withholding taxes at the time we change our intention with regard to the reinvestment of those earnings.

27

Table of Contents

Issuer Purchases of Equity Securities

The following table contains information about the shares of common stock we purchased during the quarter ended September 30, 2024:

    

    

    

    

    

    

Maximum number (or

approximate dollar

value) of

Total number of

shares (or

shares (or units)

units)

purchased as

that may

Total number of

Average price

part of publicly

yet be purchased

shares (or units)

paid per share (or

announced plans or

under the plans or

    

purchased

    

unit)

    

programs

    

programs (1)

July 1 to July 31, 2024

 

531,314

$

150.57

 

531,314

 

1,190,556

August 1 to August 31, 2024

 

$

 

 

1,190,556

September 1 to September 30, 2024

 

$

 

 

1,190,556

 

531,314

 

531,314

(1)In September 2022, when there were 1,131,301 shares remaining authorized to repurchase under the then-existing share repurchase program, the Board of Directors renewed the authorization and revised the maximum number of shares to 2,000,000 shares authorized under the stock repurchase program. Upon repurchase, shares of common stock are restored to the status of authorized but unissued shares, and we record them as a reduction in the number of shares of common stock issued and outstanding in our consolidated financial statements.

Contractual Obligations

During the first quarter of fiscal year 2025, there were no material changes outside the ordinary course of business to the information regarding specified contractual obligations contained in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024. See Notes 1, 6, 8 and 10 to the condensed consolidated financial statements for additional information regarding our contractual obligations.

Recent Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the FASB and other regulatory bodies that are adopted as of the specified effective dates. Unless otherwise discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on our Consolidated Financial Statements upon adoption. As discussed in Note 1, we are currently evaluating the potential impact on financial statement disclosures upon future adoption of ASU 2023 - 07 and ASU 2023 - 09. There were no new pronouncements adopted in the first quarter of fiscal year 2025.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

For a discussion of our exposure to market risk, refer to our market risk disclosures set forth in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024. There have been no material changes in our exposure to market risk during the three months ended September 30, 2024 from that described in the Annual Report.

28

Table of Contents

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As of September 30, 2024, the end of the period covered by this report, our management, including our Chief Executive Officer and our Chief Financial Officer, reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) of the Exchange Act). Based upon management’s review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified by the SEC and is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the first quarter of fiscal 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating our controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud within the Company have been detected.

29

Table of Contents

PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time to time, we are subject to litigation and other legal proceedings and claims  arising in the ordinary course of our business or otherwise. More information regarding legal proceedings in which we are involved can be found under Note 10, “Commitments and Contingencies” of the Notes to the Consolidated Financial Statements in Part I, Item 1 of this Report, which is incorporated by reference into this Item 1.

ITEM 1A. RISK FACTORS

The discussion of our business, financial condition and results of operations in this Quarterly Report on Form 10-Q for the period ended September 30, 2024 should be read together with the risk factors contained in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024, filed with the SEC on August 29, 2024, which describe various risks and uncertainties that could materially affect our business, financial condition and results of operations in the future. There have been no material changes to the risk factors included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

See Issuer Purchases of Equity Securities discussion under Part I, Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations, which is incorporated by reference into this Item 2.

In July 2024, we issued an aggregate of $350.0 million principal amount of 2.25% convertible senior notes due in August 2029. The 2029 Notes were issued to the initial purchasers in reliance upon Section 4(a)(2) of the Securities Act in transactions not involving any public offering. The 2029 Notes were resold by the initial purchasers to persons whom the initial purchasers reasonably believe are “qualified institutional buyers,” as defined in, and in accordance with, Rule 144A under the Securities Act. Any shares of our common stock that may be issued upon conversion of the 2029 Notes will be issued in reliance upon Section 3(a)(9) of the Securities Act as involving an exchange by us exclusively with our security holders. Initially, a maximum of 2,324,490 shares of our common stock may be issued upon conversion of the 2029 Notes based on the initial maximum conversion rate of 6.6414 shares of common stock per $1,000 principal amount of 2029 Notes which is subject to customary anti-dilution adjustment provisions.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable

ITEM 5. OTHER INFORMATION

Our directors and officers (as defined in Rule 16a-1 under the Exchange Act) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5-1 (c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. During the first quarter of fiscal 2025, none of our directors or officers informed us of the adoption, modification or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as those terms are defined in Regulation S-K, Item 408.

30

Table of Contents

ITEM 6. EXHIBITS

Exhibit
Number

    

Description

4.1

Indenture, dated as of July 19, 2024, between OSI Systems, Inc. and U.S. Bank Trust Company, National Association, as trustee (1)

4.2

Form of certificate representing the 2.25% Convertible Senior Notes due 2029 (included as Exhibit A to Exhibit 4.1) (1)

31.1

Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2

Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS

XBRL Instance Document

101.SCH

Inline XBRL Taxonomy Extension Schema

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase

104

Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101)

(1)Previously filed with our Current Report on Form 8-K filed on July 19, 2024.

31

Table of Contents

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, in the City of Hawthorne, State of California on the 25th day of October 2024.

OSI SYSTEMS, INC.

By:

/s/ Deepak Chopra

Deepak Chopra

President and Chief Executive Officer

(Principal Executive Officer)

By:

/s/ Alan Edrick

Alan Edrick

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

By:

/s/ Cary Okawa

Cary Okawa

Chief Accounting Officer

(Principal Accounting Officer)

32